Santhera Pharmaceuticals
SANN.SW
#7954
Rank
S$0.29 B
Marketcap
$23.59
Share price
3.49%
Change (1 day)
66.32%
Change (1 year)

EPS for Santhera Pharmaceuticals (SANN.SW)

EPS in 2018 (TTM): -$50.75

According to Santhera Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$16.61. In 2022 the company made an earnings per share (EPS) of -$16.61 an increase over its 2021 EPS that were of -$23.32.

EPS history for Santhera Pharmaceuticals from 2006 to 2018

Annual EPS

Year EPS Change
2022-$16.61-28.75%
2021-$23.32-69.23%
2020-$75.78222.64%
2019-$23.49-77.65%
2018-$105.09-5.34%
2017-$111.0252.2%
2016-$72.94-593.67%
2015$14.77-165.72%
2014-$22.48-2.15%
2013-$22.98-81.35%
2012-$123.2115.64%
2011-$106.54145.81%
2010-$43.34-53.37%
2009-$92.95-152.24%
2008$177.93-270.36%
2007-$104.44-33.09%
2006-$156.09